Company: BKYI
Filing Date: 2025-11-21
Form Type: S-1
Source: 0001437749-25-036032
Chunk: 21

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-11-21
Form: S-1
Chunk 21
---
 above the total number of authorized shares of the class) or decrease (but not below the number of shares then outstanding);                                                                                                                                                                   |
| ● | whether dividends, if any, will be cumulative or non-cumulative and the dividend rate of the series;                                                                                                                                                                                                                                                                                                                                                       |
| ● | the dates at which dividends, if any, will be payable;                                                                                                                                                                                                                                                                                                                                                                                                     |
| ● | the redemption rights and price or prices, if any, for shares of the series;                                                                                                                                                                                                                                                                                                                                                                               |
| ● | the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series;                                                                                                                                                                                                                                                                                                                                                 |
| ● | the amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution or winding-up of our affairs;                                                                                                                                                                                                                                                                                                            |
| ● | whether the shares of the series will be convertible into shares of any other class or series, or any other security, of the Company or any other corporation, and, if so, the specification of the other class or series or other security, the conversion price or prices or rate or rates, any rate adjustments, the date or dates as of which the shares will be convertible and all other terms and conditions upon which the conversion may be made; |
| ● | restrictions on the issuance of shares of the same series of any other class or series; and                                                                                                                                                                                                                                                                                                                                                                |
| ● | the voting rights, if any, of the holders of the series.                                                                                                                                                                                                                                                                                                                                                                                                   |

We could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or a majority, of the holders of our common stock might believe to be in their best interests or in which the holders of our common stock might receive a premium for their common stock over the market price of that common stock. Additionally, the issuance of preferred stock may adversely affect the holders of our common stock by restricting dividends on the common stock, diluting the voting power of the common stock, or subordinating the liquidation rights of the common stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of our common stock.

Certain Effects of Delaware Law and Certificate of Incorporation and Bylaw Provisions

Authorized But Unissued Stock. We are authorized to issue 175,000,000 shares of capital stock, consisting of 170,000,000 shares of common stock and 5,000,000